Prebiotics in Peritoneal Dialysis



Status:Completed
Conditions:Renal Impairment / Chronic Kidney Disease
Therapuetic Areas:Nephrology / Urology
Healthy:No
Age Range:21 - Any
Updated:11/21/2018
Start Date:April 21, 2016
End Date:February 28, 2018

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The Prebiotics in Peritoneal Dialysis trial is a non-randomized, open-label, crossover study
of p-inulin for patients with end-stage renal disease treated with peritoneal dialysis.


Inclusion Criteria:

- Peritoneal dialysis therapy for end-stage renal disease

- ≥30 days since dialysis initiation

- Ability to provide informed consent

Exclusion Criteria:

- Use of pre- or pro-biotics during the past 2 months

- Consumption of pro-biotic yogurt during the past 2 weeks

- Use of antibiotics within the past 2 months

- Presence of chronic infection

- Chronic gastrointestinal condition other than constipation

- Cirrhosis or chronic active hepatitis

- Stomach/intestinal resection

- PD access problems

- Anticipated kidney transplant or transfer to another dialysis unit within 9 months

- Expected survival < 9 months

- Pregnancy, anticipated pregnancy, or breastfeeding

- Incarceration

- Participation in another intervention study

- Severe anemia defined as hemoglobin <9.0 g/dl
We found this trial at
2
sites
DaVita Georgetown Home Training Unit
Washington, District of Columbia 20007
?
mi
from
Washington,
Click here to add this to my saved trials
DaVita K Street
2131 K Street Northwest
Washington, District of Columbia 20037
?
mi
from
Washington,
Click here to add this to my saved trials